How to Buy Ionis Pharmaceuticals Stock

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States.

Ionis Pharmaceuticals stock last closed at $35.73, down 0.47% from the previous day, and has decreased 27.69% in one year. It has underperformed other stocks in the Biotechnology industry by 0.17 percentage points. Ionis Pharmaceuticals stock is currently +7.2% from its 52-week low of $33.33, and -34.37% from its 52-week high of $54.45.

At the moment, there are 157.9M IONS shares outstanding. The market capitalization of IONS is $5.64B. In the past 24 hours, 622,387 IONS shares were traded.

How to Buy Ionis Pharmaceuticals Stock

Wondering how to invest in Ionis Pharmaceuticals stock? Here's how.

  1. Figure out where to buy Ionis Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you determine where to buy Ionis Pharmaceuticals stock.
  2. Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Fund your brokerage account: Choose your method of payment and add your details.
  4. Research Ionis Pharmaceuticals stock: The Ionis Pharmaceuticals ticker symbol is IONS. Is Ionis Pharmaceuticals stock a good investment? Should you buy shares of IONS? How do IONS's underlying business fundamentals look? Do top analysts think Ionis Pharmaceuticals is a good buy? Why has IONS's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if IONS is a good stock to buy).
  5. Execute your IONS buy order: Decide if you will purchase IONS shares at the current market price or use a limit order to purchase IONS stock at a specific price.
  6. Get the latest news on your investment in IONS: Create a watchlist to the latest updates on your investment in Ionis Pharmaceuticals stock.

Step 1: Figure out where to buy Ionis Pharmaceuticals stock

You will need a brokerage account to access the NASDAQ market and buy IONS shares.

A brokerage account enables you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our experience, eToro is the best brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global financial markets: From Technology to Healthcare, New York to London — you can fill your portfolio with stocks from the world's leading exchanges.
  • Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your stock purchase by creating an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've picked your brokerage, the next step is to fill out some personal information so you can invest in IONS today.

How to Set Up a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to open a new brokerage account.
  1. Submit your data by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you've filled out your info on the best stock app, your next step is to transfer the money for your investment:

Check out the walkthrough below to see the process of transferring money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Ionis Pharmaceuticals stock

Once you have decided on the best place to buy Ionis Pharmaceuticals stock, it's absolutely critical to evaluate their stock prior to investing, so you actually comprehend the risk and opportunity.

Ionis Pharmaceuticals quick stats

IONS Price
$35.73
1w %
5.06%
1y %
-27.69%
5y %
-44.14%
P/E
-14.64x
P/B
8.52x
P/S
6.61x
PEG
N/A
Revenue
$803.07M
Earnings
-$358.81M
Fore. Rev. Growth
6.17%
Fore. Earn. Growth
N/A
Market Cap
$5.64B
Next Earnings
N/A
Next Dividend
N/A

Ionis Pharmaceuticals Fundamentals

WallStreetZen was created to help average investors perform more accurate fundamental analysis quickly.

You can view all of the due diligence checks on IONS's stock page.

How is IONS stock valued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge IONS's fair value.

Using relative valuations ratios:

  • IONS could be overvalued based on its P/B ratio of 8.52x, relative to Biotechnology industry P/B ratio of 5.61x

You can access additional valuation research on IONS's stock here.

IONS Financials at a glance

Signs that IONS is financially healthy:

  • There are more short-term assets than long-term liabilities on the IONS balance sheet.
  • There are more short-term assets than short-term liabilities on the IONS balance sheet.
  • IONS has cash burn of 370885000. It has sufficient cash and short-term investments to cover this for at least one year.
  • IONS has $2.48B in cash and short term investments. This is sufficient to cover its annual cash burn of $370.89M.

Signs that IONS is not financially healthy:

  • IONS profit margin has gone up by 0.22 percentage points in the past year, but the company is still unprofitable.
  • IONS has a relatively high debt to equity ratio of 3.65.
  • Total IONS debt is higher than 5 years ago, relative to shareholder equity.

Do analysts think it's a good time to buy Ionis Pharmaceuticals stock

Out of 14 Equities analysts who track IONS, the consensus analyst rating on IONS is a Buy

It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.

Most Recent IONS Analyst Recommendations

Jessica Fye, a top 11% analyst from JP Morgan maintains IONS with a hold rating and raises their IONS price target from $50.00 to $55.00, on Aug 26, 2024.

Salveen Richter, a bottom 14% analyst from Goldman Sachs maintains IONS with a strong sell rating and raises their IONS price target from $33.00 to $37.00, on Aug 2, 2024.

Gena Wang, a bottom 7% analyst from Barclays maintains IONS with a hold rating and raises their IONS price target from $45.00 to $51.00, on Aug 2, 2024.

Kostas Biliouris, a bottom 5% analyst from BMO Capital downgrades IONS to a hold rating and lowers their IONS price target from $67.00 to $60.00, on Aug 2, 2024.

Mani Foroohar, a bottom 2% analyst from Leerink Partners upgrades IONS to a buy rating and raises their IONS price target from $53.00 to $62.00, on Jul 24, 2024.

You can dive deeper into what analysts are forecasting on the Ionis Pharmaceuticals stock forecast page.

Metrics for Advanced IONS Traders

SMA10
34.76
SMA20
36.6
SMA50
38.21
SMA100
42.73
SMA200
42.53
MACD
-1.09
MACD Signal
-1.16
MACD Histogram
0.07
RSI
43.68
Stochastic %K
34.69
Stochastic %D
30.69
StochRSI %K
78.74
StochRSI %D
69.87

Is IONS Growing Revenue?

Last year, IONS revenue was $803.07M. Over the past 5 year, IONS's revenue has increased by -0.44% per year. This was slower than the Biotechnology industry average of 67.67%.

Find out more about IONS's earnings and revenue performance here.

Are IONS executives and large shareholders buying or selling the stock?

In the last year, insiders at IONS have sold more shares than they have bought.

Joseph Loscalzo, Director of IONS, was the latest IONS insider to sell. They sold $511,426.39 worth of IONS shares on Nov 12, 2024.

Get more info about who owns IONS shares here.

Can I get consistent income from IONS stock?

No, Ionis Pharmaceuticals doesn't provide an income stream by paying out dividends.

IONS Social Trading Data

One of the major reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to see what other traders have to say.

Step 5: Execute your IONS buy order

You have two main types of orders:

  • Market order: A market order is an order to buy or sell a security at the best available price.
    Market orders are usually sufficient.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at a specific price limit, use a limit order.

Click the Open button and eToro will place your order.

If you require more help investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get the latest news on your investment in IONS

Now that you own some shares in IONS, you'll want to keep up with your new investment.

Add IONS to a watchlist to keep tabs on your IONS stock.

IONS Feed

How to Buy Stock in Ionis Pharmaceuticals

To summarize, here are the 6 steps you need to take to buy Ionis Pharmaceuticals stock right now:

  1. Figure out where to buy Ionis Pharmaceuticals stock
  2. Create a brokerage account
  3. Fund your brokerage account
  4. Research Ionis Pharmaceuticals stock
  5. Execute your IONS buy order
  6. Get the latest news on your investment in IONS

If you require a place to buy stocks, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep track of your investment in Ionis Pharmaceuticals, click below.

NASDAQ: IONS
$35.73-0.17 (-0.47%)
Updated Nov 29, 2024
Open eToro Account
NASDAQ: IONS
$35.73-0.17 (-0.47%)
Updated Nov 29, 2024
Open eToro Account

FAQ

How much does it cost to buy one Ionis Pharmaceuticals share?

As of Nov 29, 2024, it costs $35.73 to buy one share of Ionis Pharmaceuticals stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.28 shares of IONS.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Ionis Pharmaceuticals stock?

According to 14 Wall Street analysts who monitor Ionis Pharmaceuticals, their consensus recommendation is to buy Ionis Pharmaceuticals stock.

What is the best way to buy Ionis Pharmaceuticals stock?

One way to place an order for Ionis Pharmaceuticals stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.